INGRAM-MICRO-CLOUD
12.11.2021 09:02:10 CET | Business Wire | Press release
Ingram Micro Cloud today announced that it is now distributing a full range of Amazon Web Services, Inc. (AWS) products and services to its reseller network in Hungary and Poland. The move bolsters the global offering of Ingram Micro’s Cloud Marketplace, one of the world’s most comprehensive and broadly adopted set of cloud solutions.
Ingram Micro Cloud, an AWS Advanced Consulting Partner and AWS Distributor, announced its global Strategic Collaboration Agreement (SCA) with AWS in March this year. One of the central objectives of the agreement between the business leaders is extending the global reach and footprint of AWS and its partners. As part of this global expansion, Ingram Micro Cloud is now delivering a complete portfolio of AWS solutions to resellers in Hungary and Poland, in addition to its recent launches in France, Mexico, Australia, and New Zealand, which were part of a series of authorizations in 2021. As a result of the SCA with AWS, Ingram Micro expects its large network of partners to see new opportunities to meet customer needs and expand their infrastructure as a service (IaaS) business.
"The distribution alliance between Ingram Micro Cloud and AWS in our region is a great strategic milestone for us,” said Attila Virágh, Managing Director at Ingram Micro Hungary. “Teaming further with AWS brings tremendous opportunity and additional business value to our channel partners within the cloud ecosystem by helping them execute at scale, and quickly meet the business needs of their customers.”
“I’m happy to see AWS joining our marketplace offering in Central and Eastern Europe. I am confident this relationship will significantly contribute to the acceleration of as-a-service models and customers’ cloud migration,” said Jacek Jedraszka, Managing Director at Ingram Micro Poland.
AWS and Ingram Micro Cloud are working together to bolster Ingram Micro Cloud’s current skills and offerings, as well as develop new resources to support channel partners in managing end customers. Ingram Micro Cloud currently provides an AWS Cloud Center of Excellence (CCoE) team with 200+ AWS Certifications, AWS Professional Services, AWS Managed Services, AWS Well-Architected Services, AWS Operations and Billing Services, and more.
Ingram Micro Cloud also covers a wide range of partner enablement and support initiatives to help AWS Partners build an AWS practice through its partner programs, which provide end-to-end engagement models for Ingram Micro Cloud to enable systems integrators (SIs) and independent software vendors (ISVs) in their journey on the cloud.
“We are pleased to differentiate our broad portfolio of cloud services with the addition of AWS on our Cloud Marketplace,” said Nora Papp, Head of Cloud for Central and Eastern Europe at Ingram Micro. “Through this important expansion of pioneering solutions and services, Ingram Micro Cloud is offering our reseller partners the seamless capability to build a successful AWS practice and deliver greater value to their customers.”
Further information about Ingram Micro Cloud’s AWS offerings can be found here .
About Ingram Micro Cloud
Ingram Micro Cloud brings together innovators and problem solvers to help the world accomplish more. It facilitates and manages the cloud’s complex digital value chain—all powered by CloudBlue technology. Ingram Micro Cloud operates in 76 countries with over 55,000 reseller partners, and its Cloud Marketplace serves 17.2 million seats, offering more than 120 cloud solutions. With unmatched global reach, easy access to automated go-to-market and integration tools, deep technical expertise, and a curated selection of scalable SaaS and IaaS solutions, Ingram Micro Cloud helps vendors, resellers and managed service providers by offering More as a Service. Detailed information is available at www.IngramMicroCloud.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211112005051/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer House of Code for at styrke teknologi- og dataløsninger26.6.2026 20:01:00 CEST | Pressemeddelelse
Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomheder. Virksomheden besidder dyb ekspertise inden for energihandel og risikostyring og hjælper organisationer med systemimplementering, forretningstransformation, dataautomatisering og ai-underbygget modernisering af arbejdsgange. Deres proprietære platform, Enterprise Platform for Integrated Compliance (EPIC), skaber en mere effektiv datastyring, automatiserer rapporteringsprocesser, forbedrer den driftsmæssige gennemsigtighed på tværs af virksomhedssystemer og skaber et fundament for opbygning af intelligente, agentbaserede arbe
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press release
Receives AI Governance & Risk Excellence Award at OpenAI Partner SummitCapco’s UK AI Lab wins OpenAI Codex Hackathon Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solutio
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
